Published in Gut on April 01, 1979
Pilot study of combination treatment for gall stones with medium dose chenodeoxycholic acid and a terpene preparation. Br Med J (Clin Res Ed) (1984) 1.19
Ursodeoxycholic acid therapy and biliary lipids--a dose-response study. Gut (1980) 0.99
Adjunct to bile-acid treatment for gall-stone dissolution: low-dose chenodeoxycholic acid combined with a terpene preparation. Br Med J (Clin Res Ed) (1981) 0.94
Treatment of biliary duct stones with a terpene preparation. Br Med J (Clin Res Ed) (1981) 0.86
Effect of Rowachol on biliary lipid secretion and serum lipids in normal volunteers. Gut (1985) 0.79
The effects of 3,5,5-trimethylcyclohexanol on hepatic cholesterol synthesis, bile flow and biliary lipid secretion in the rat. Br J Pharmacol (1984) 0.75
Dissolution of gall stones with an ursodeoxycholic acid menthol preparation: a controlled prospective double blind trial. Gut (1988) 0.75
Phosphorus assay in column chromatography. J Biol Chem (1959) 60.56
The physicochemical basis of cholesterol gallstone formation in man. J Clin Invest (1968) 5.80
Dissolution of cholesterol gallstones by chenodeoxycholic acid. N Engl J Med (1972) 4.26
Enzymic analysis of steroid hormones. Methods Biochem Anal (1960) 3.55
Letter: A simple calculation of the lithogenic index of bile: expressing biliary lipid composition on rectangular coordinates. Gastroenterology (1973) 3.09
The solubility of cholesterol in aqueous solutions of bile salts and lecithin. Z Ernahrungswiss (1971) 2.75
Simplified rapid technic for the extraction and determination of serum cholesterol without saponification. Clin Chem (1956) 2.65
Gallstone dissolution in man using chenodeoxycholic acid. Lancet (1972) 2.55
Efficacy and specificity of chenodeoxycholic acid therapy for dissolving gallstones. N Engl J Med (1973) 1.98
Chenodeoxycholic acid treatment of gallstones. A follow-up report and analysis of factors influencing response to therapy. N Engl J Med (1975) 1.97
Ursodeoxycholic acid treatment of gallstones. Dose-response study and possible mechanism of action. Lancet (1978) 1.32
Treatment of gallstones with chenodeoxycholic acid and phenobarbital. N Engl J Med (1975) 1.30
Terpenes in the treatment of gallstones. Minn Med (1971) 1.24
Determination of hepatic 3-hydroxy-3-methylglutaryl CoA reductase activity in man. J Lipid Res (1974) 1.21
Chenodeoxycholic acid therapy of gallstones. Clin Gastroenterol (1977) 1.16
Hepatic cholesterol metabolism in patients with gallstones. Gastroenterology (1975) 1.08
Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones. J Lab Clin Med (1976) 1.07
Chenotherapy for gallstone dissolution. I. Efficacy and safety. JAMA (1978) 1.05
The use of d-limonene preparation as a dissolving agent of gallstones. Am J Dig Dis (1976) 0.92
Effect of ioglycamide (Biligram) on bile flow and biliary lipid secretion in man. Gut (1978) 0.89
[Clinico-pathological studies on cholelithiasis. II. Medical treatment of choleithiasis experience of therapy with terebene oil preparation]. Naika Hokan (1965) 0.84
The influence of beta-sitosterol on biliary cholesterol saturation and bile acid kinetics in man. Scand J Gastroenterol (1978) 0.84
Effect of d-limonene and related compounds on bile flow and biliary lipid composition in rats and dogs. Life Sci (1976) 0.83
[Studies on the potency of action of several choleretics]. Dtsch Med J (1966) 0.82
[Therapy of bile duct diseases with a terpene combination]. Medizinische (1957) 0.80
Rowachol, a proprietary terpene preparation, dissolves cholesterol gallstones [proceedings]. Br J Clin Pharmacol (1978) 0.80
Letter: Beta-sitosterol and chenodeoxycholic acid in the treatment of cholesterol gallstones. Lancet (1975) 0.79
Identification of Clostridium difficile as a cause of pseudomembranous colitis. Br Med J (1978) 8.47
Diagnosis of pseudomembranous colitis. Br Med J (1978) 5.96
Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea. Br Med J (1978) 4.99
Prospective audit of upper gastrointestinal endoscopy in two regions of England: safety, staffing, and sedation methods. Gut (1995) 4.70
Optimal timing of operation for bleeding peptic ulcer: prospective randomised trial. Br Med J (Clin Res Ed) (1984) 3.82
Faecal incontinence after childbirth. Br J Obstet Gynaecol (1997) 3.35
Sedation for upper gastrointestinal endoscopy: results of a nationwide survey. Gut (1991) 3.14
14C-urea breath analysis, a non-invasive test for Campylobacter pylori in the stomach. Lancet (1987) 2.68
Prevention of hypoxaemia during upper-gastrointestinal endoscopy by means of oxygen via nasal cannulae. Lancet (1987) 2.60
Gallstone dissolution in man using chenodeoxycholic acid. Lancet (1972) 2.55
Comparison between systemic and oral antimicrobial prophylaxis in colorectal surgery. Lancet (1979) 2.40
Intravenous midazolam: a study of the degree of oxygen desaturation occurring during upper gastrointestinal endoscopy. Br J Clin Pharmacol (1987) 2.36
Depth of insertion at flexible sigmoidoscopy: implications for colorectal cancer screening and instrument design. Endoscopy (1999) 2.23
Cimetidine and ranitidine: comparison of effects on hepatic drug metabolism. Br Med J (1980) 2.09
Stimulated gracilis neosphincter--not as good as previously thought. Report of four cases. Dis Colon Rectum (1995) 2.04
Vitamin K administration in the newborn: statement by Fetus and Newborn Committee of Paediatric Society of New Zealand. N Z Med J (1992) 1.99
Diarrhoea and pseudomembranous colitis after gastrointestinal operations. A prospective study. Lancet (1978) 1.98
Chenodeoxycholic acid treatment of gallstones. A follow-up report and analysis of factors influencing response to therapy. N Engl J Med (1975) 1.97
Totally stapled abdominal restorative proctocolectomy. Br J Surg (1989) 1.92
Anorectal function after abdominal rectopexy: parameters of predictive value in identifying return of continence. Br J Surg (1989) 1.89
Simple half-gram stain for showing presence of Campylobacter pyloridis in sections. J Clin Pathol (1987) 1.84
Cryotherapy for liver metastases: a new approach. Br J Surg (1989) 1.73
Factors influencing human gallstone dissolution in monkey, dog, and human bile. Gut (1972) 1.73
Cimetidine is unlikely to increase formation of intragastric N-nitroso-compounds in patients taking a normal diet. Lancet (1981) 1.70
Helicobacter pylori eradication in patients with peptic ulcer disease: clinical consequences and financial implications. Q J Med (1994) 1.67
Antibiotics in biliary disease: the relative importance of antibiotic concentrations in the bile and serum. Gut (1976) 1.66
Prospective evaluation of the McMurray test. Am J Sports Med (1993) 1.64
Influence of inflammatory bowel disease on intestinal microflora. Gut (1978) 1.61
Comparison between general and local anaesthesia for repair of groin hernias. Ann R Coll Surg Engl (1979) 1.60
Management of faecal incontinence and results of surgical treatment. Br J Surg (1983) 1.59
The value of radiology in predicting gallstone type when selecting patients for medical treatment. Gut (1975) 1.58
Clinical and economic consequences of wound sepsis after appendicectomy and their modification by metronidazole or povidone iodine. Lancet (1981) 1.57
Anti-Helicobacter pylori therapy: clearance, elimination, or eradication? Lancet (1991) 1.57
Prospective trials of minor surgical procedures and high-fibre diet for haemorrhoids. Br Med J (1979) 1.57
Omeprazole and Helicobacter pylori: temporary suppression rather than true eradication. Aliment Pharmacol Ther (1991) 1.56
Long-term study of re-infection following successful eradication of Helicobacter pylori infection. Aliment Pharmacol Ther (2006) 1.54
Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers. J Clin Invest (1982) 1.54
Prospective audit of perforation rates following upper gastrointestinal endoscopy in two regions of England. Br J Surg (1995) 1.53
Risk factors for intra-abdominal sepsis after surgery in Crohn's disease. Dis Colon Rectum (2000) 1.52
Acute urinary retention in the female. Br J Urol (1975) 1.51
Colonoscopy--is sedation necessary and is there any role for intravenous propofol? Endoscopy (2000) 1.51
Stapled versus sutured closure of loop ileostomy: a randomized controlled trial. Ann Surg (2000) 1.50
Evaluation of the inflammatory infiltrate in pouchitis with 111In-labeled granulocytes. Gastroenterology (1993) 1.50
Antibiotic-associated colitis--a review of 66 cases. Br J Surg (1979) 1.49
Omentoplasty for persistent perineal sinus after proctectomy for Crohn's disease. Am J Surg (2001) 1.47
Outcome of endoscopy and barium radiography for acute upper gastrointestinal bleeding: controlled trial in 1037 patients. Br Med J (Clin Res Ed) (1982) 1.46
Hazards of surgical treatment due to microorganisms in the bile. Surgery (1974) 1.46
Randomized trial comparing three forms of pelvic floor repair for neuropathic faecal incontinence. Br J Surg (1993) 1.45
Effect of different doses of chenodeoxycholic acid on bile-lipid composition and on frequency of side-effects in patients with gallstones. Lancet (1974) 1.44
Long term results of anorectal myectomy for chronic constipation. Br J Surg (1989) 1.44
One-dose antibiotic prophylaxis against wound infection after appendicectomy: a randomized trial of clindamycin, cefazolin sodium and a placebo. Br J Surg (1979) 1.43
Operative choledochoscopy. Br J Surg (1979) 1.43
Faecal toxin and severity of antibiotic-associated pseudomembranous colitis. J Clin Pathol (1981) 1.43
Results of Marlex mesh abdominal rectopexy for rectal prolapse in 100 consecutive patients. Br J Surg (1983) 1.42
Multivariate analysis of clinical and operative findings associated with bilary sepsis. Br J Surg (1976) 1.41
The present position concerning gallstone dissolution. Gut (1974) 1.41
Pouchitis. Br J Surg (1994) 1.41
A controlled trial of parenteral prophylactic gentamicin therapy in biliary surgery. Br J Surg (1975) 1.41
Introduction of laparoscopic cholecystectomy in a large teaching hospital: independent audit of the first 3 years. Br J Surg (1995) 1.40
Skeletal applications of videofluoroscopy. J Manipulative Physiol Ther (1990) 1.40
Protection of the bovine fetus from bovine viral diarrhoea virus by means of a new inactivated vaccine. Vet Rec (1995) 1.39
Comparison of minimal and conventional surgery in patients with bleeding peptic ulcer: a multicentre trial. Br J Surg (1991) 1.39
Tiguvon spot-on and flea control in dogs and cats. Vet Rec (1997) 1.39
Anal pressures in hemorrhoids and anal fissure. Am J Surg (1977) 1.39
Incidence of pathogenic bacteria from mesenteric lymph nodes and ileal serosa during Crohn's disease surgery. Br J Surg (1984) 1.38
Triradiate dilator in laparoscopic cholecystectomy. Br J Surg (1994) 1.38
Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis. Br J Surg (1994) 1.36
Abdominal resection rectopexy with pelvic floor repair versus perineal rectosigmoidectomy and pelvic floor repair for full-thickness rectal prolapse. Br J Surg (1994) 1.36
Micro-organisms in the bile. A preventable cause of sepsis after biliary surgery. Ann R Coll Surg Engl (1977) 1.35
Influence of neomycin and metronidazole on colonic microflora of volunteers. J Antimicrob Chemother (1979) 1.34
Mortality in patients with bleeding peptic ulcer when those aged 60 or over are operated on early. BMJ (1990) 1.32
First clinical results with a real time, electronic imager as an aid to colonoscopy. Gut (1995) 1.31
Intraductal infusion of mono-octanoin: experience in 24 patients with retained common-duct stones. Lancet (1981) 1.30
Faecal diversion for Crohn's colitis: a model to study the role of the faecal stream in the inflammatory process. Gut (1994) 1.29
Measurement of bile acids in fasting gastric aspirates: an objective test for bile reflux after gastric surgery. Gut (1978) 1.29
Prophylaxis against anaerobic sepsis in bowel surgery. Br J Surg (1976) 1.28
Measurement of exhaled chlorofluorocarbons. Lancet (1988) 1.27
Crohn's disease in the elderly. Gut (1985) 1.27
Prevention of wound sepsis in gastro-intestinal surgery. Br J Surg (1977) 1.27
Lithogenic bile in patients with ileal dysfunction. Gut (1972) 1.26
Delayed release peppermint oil capsules (Colpermin) for the spastic colon syndrome: a pharmacokinetic study. Br J Clin Pharmacol (1984) 1.26
Intravenous midazolam for upper gastrointestinal endoscopy: a study of 800 consecutive cases relating dose to age and sex of patient. Br J Clin Pharmacol (1987) 1.26
Morning emergency operating list: effects of implementation. Ann R Coll Surg Engl (1993) 1.26
The [14C]-aminopyrine breath test. A comparison of different forms of analysis. Br J Clin Pharmacol (1979) 1.26
"Eradication" of Campylobacter pylori: are we being misled? Lancet (1988) 1.26
A comparison of winged steel needles and Teflon cannulas in maintaining intravenous access during gastrointestinal endoscopy. Gastrointest Endosc (1993) 1.23
Natural history of perianal Crohn's disease. Ten year follow-up: a plea for conservatism. Am J Surg (1980) 1.22
Loop ileostomy after ileal pouch-anal anastomosis--is it necessary? Dis Colon Rectum (1991) 1.22
Randomized trial of loop ileostomy in restorative proctocolectomy. Br J Surg (1992) 1.20
Non-radiological technique for three-dimensional imaging of endoscopes. Lancet (1993) 1.20
Spontaneous rupture of the oesophagus. Avoidance of postoperative morbidity. Br J Surg (1972) 1.20
Bleeding patterns in colorectal cancer: the effect of aspirin and the implications for faecal occult blood testing. Br J Surg (1982) 1.20
Pilot study of combination treatment for gall stones with medium dose chenodeoxycholic acid and a terpene preparation. Br Med J (Clin Res Ed) (1984) 1.19
National audit of complicated diverticular disease: analysis of index cases. Br J Surg (1994) 1.18
Serum lipids in cholelithiasis: effect of chenodeoxycholic acid therapy. Br Med J (1973) 1.17
Antimicrobial susceptibilities of clinical isolates of Acinetobacter baumannii from Singapore. Antimicrob Agents Chemother (1994) 1.17
Routine laboratory assessment of postoperative chest infection: a prospective study. J Clin Pathol (1977) 1.17
Duodenogastric reflux: a cause of gastric mucosal hyperaemia and symptoms after operations for peptic ulceration. Gut (1975) 1.17
The prevalence of anal sphincter defects in faecal incontinence: a prospective endosonic study. Gut (1993) 1.17